Frank A. Holler, Director at Xenon Pharmaceuticals Inc. (XENE), sold 34,524 shares at $7.70 ($274K) on 2016-08-18, disclosed to the SEC on 2016-08-18.
Open-market sale of $274k XENE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.25 | 6,863 | $57K | 20.7% |
| 2 | $8.25 | 6,863 | $57K | 20.7% |
| 3 | $7.89 | 1,600 | $13K | 4.6% |
| 4 | $7.70 | 9,599 | $74K | 27.0% |
| 5 | $7.70 | 9,599 | $74K | 27.0% |
| Total | $7.93 avg | 34,524 |
| $274K |
| 100% |
| Filing → |
| XENE | SELL | 2019-09-18 | $88K | — | Filing → |
| XENE | SELL | 2016-12-19 | $236K | — | Filing → |
| XENE | SELL | 2016-08-23 | $183K | — | Filing → |